Fluphenazine Decanoate
NDC Package 64725-0272-1

11-digit billing NDC: 64725027201

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Fluphenazine Decanoate is injection is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics).Fluphenazine Decanoate Injection has not been shown effective in the management of behavioral complications in patients with mental retardation. Marketed by Tya Pharmaceuticals, this product is identified by NDC 64725-0272 and is authorized under FDA application ANDA071413.

Identification & Billing

NDC Package Code
64725-0272-1
Package Description
1 mL in 1 CARTON
Product Code
11-Digit Billing Format
64725027201
RxNorm Crosswalk
  • RxCUI: 859824 - fluPHENAZine decanoate 25 MG/ML Injectable Solution
  • RxCUI: 859824 - fluphenazine decanoate 25 MG/ML Injectable Solution

Clinical Specifications

Proprietary Name
Fluphenazine Decanoate
Dosage Form
-
Usage Information
Fluphenazine Decanoate Injection is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics).Fluphenazine Decanoate Injection has not been shown effective in the management of behavioral complications in patients with mental retardation.

Regulatory & Marketing

Labeler Name
Tya Pharmaceuticals
FDA Application #
ANDA071413
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-15-2010
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64725-0272-1 identifies a specific commercial package of 1 ml in 1 carton of Fluphenazine Decanoate, labeled by Tya Pharmaceuticals. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Tya Pharmaceuticals on December 15, 2010. The current certification is valid through December 31, 2017.

How is this Tya Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64725027201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
64725-0272-1
11-Digit CMS (5-4-2)
64725-0272-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.